Inhibit the expression of Tgfbr1 by direct targeting to disrupt the TGF-β/Smad/TLR3 pathway, thus repressing renal fibrosis and the secretion of inflammatory factors in LN. The gene discussed is TGFBR1; the disease is lobular neoplasia.